HIV-1 Infection in Children: Current Practice and Future Predictions
This review will discuss the global epidemiology and clinical classification of HIV-1 in children, and the management and treatment principles in an industrialized economic setting. The epidemiology highlights the burden of disease that the global epidemic is placing on less-developed countries. Extending the benefits of advances in treatment to children and families in high prevalence regions is a priority and a challenge for health care systems and governments internationally.
KeywordsViral Load Virological Failure Infected Child Undetectable Viral Load Thymic Output
Unable to display preview. Download preview PDF.
- Centers for Disease Control. (1994). 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43(RR-12), 1–10.Google Scholar
- Childrens HIV Association of the UK and Ireland website, [www.bhiva.org/chiva]
- De Rossi, A., Walker, A.S., Klein, N., De Forni, D., King, D., and Gibb, D.M. for PENTA (2002). Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. J. Infect. Dis. 186, 312–320.PubMedCrossRefGoogle Scholar
- Gibb, D.M., Duong, T., Tookey, P.A., Sharland, M., Tudor-Williams, G., Noveli, V. et al., On behalf of the National Study of HIV in Pregnancy and Childhood (NSHPC) and the Collaborative HIV Paediatric Study (CHIPS). (2003). Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ, 327(7422), 1019.Google Scholar
- Gulick R.M., Ribaudo H.J., Shikuma C.M. et al. (2003). ACTG 5095: A comparative study of 3 protease inhibitor-sparing antiretroviral regimens for the initial treatment of HIV infection. 2nd IAS Conference on HIV Pathogenesis and Treatment. Paris, France 13-16 July [Abstract Oral 41].Google Scholar
- Paediatric European Network for Treatment of AIDS (PENTA). (2002). Comparison of dual nucleoside-analogue reverse transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: The PENTA 5 randomized trial. Lancet 359, 733–740.CrossRefGoogle Scholar
- Shingadia, D., Viani, R.M., Yogev, R., Binns, H., Dankner, W.M., Spector, S.A., and Chadwick, E.G. (2000). Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus. Pediatrics 105, E80.PubMedCrossRefGoogle Scholar
- Squires K.E., Thiry A., Giordano et al. (2002). Atazanavir QD vs efavirenz 3 QD with fixed dose ZDV +3TC BID comparison of antiviral efficacy and safety. Week 48 results from BMS A1424-034 phase III pivotal study. XXXXII ICAAC., Chicago.Google Scholar
- Staszewski, S., Morales-Ramirez, J., Tashima, K.T., Rachlis, A., Skiest, D., Stanford, J. et al. (1999). Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N. Engl. J. Med. 341, 1865–1873.PubMedCrossRefGoogle Scholar
- United Nations Programme on HIV/AIDS (UNAIDS). website: http://www.unaids.org